Is combination therapy with inhaled anticholinergics and β₂-adrenoceptor agonists justified for chronic obstructive pulmonary disease?REDDY, Chakravarthy B; KANNER, Richard E.Drugs & aging. 2007, Vol 24, Num 8, pp 615-628, issn 1170-229X, 14 p.Article

Variability of spirometry in chronic obstructive pulmonary disease : Results from two clinical trialsHERPEL, Laura B; KANNER, Richard E; LEE, Shing M et al.American journal of respiratory and critical care medicine. 2006, Vol 173, Num 10, pp 1106-1113, issn 1073-449X, 8 p.Article

Loss of bone density with inhaled triamcinolone in lung health study IISCANLON, Paul D; CONNETT, John E; KANNER, Richard E et al.American journal of respiratory and critical care medicine. 2004, Vol 170, Num 12, pp 1302-1309, issn 1073-449X, 8 p.Article

The effects of a smoking cessation intervention on 14.5-year mortality : A randomized clinical trialANTHONISEN, Nicholas R; SKEANS, Melissa A; WISE, Robert A et al.Annals of internal medicine. 2005, Vol 142, Num 4, pp 233-239, issn 0003-4819, 7 p.Article

Further evidence for the role of genes on chromosome 2 and chromosome 5 in the inheritance of pulmonary functionMALHOTRA, Alka; PEIFFER, Andy P; RYUJIN, Darin T et al.American journal of respiratory and critical care medicine. 2003, Vol 168, Num 5, pp 556-561, issn 1073-449X, 6 p.Article

Lower respiratory illnesses promote FEV₁ decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: Results from the Lung Health StudyKANNER, Richard E; ANTHONISEN, Nicholas R; CONNETT, John E et al.American journal of respiratory and critical care medicine. 2001, Vol 164, Num 3, pp 358-364, issn 1073-449XArticle